Sertraline and Alprazolam in the Treatment of Panic Disorder
A compared, 12 week, placebo controlled study, with fixed dose, outpatient study of patients diagnosed with panic disorder with and without agoraphobia according to ICD-10, was conducted to evaluate the efficacy and safety of sertraline and alprazolam. The study included 40 patients, divided in two...
Main Authors: | Saida Fišeković, Svjetlana Loga-Zec |
---|---|
Format: | Article |
Language: | English |
Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2005-05-01
|
Series: | Biomolecules & Biomedicine |
Subjects: | |
Online Access: | https://www.bjbms.org/ojs/index.php/bjbms/article/view/3292 |
Similar Items
-
Carbon dioxide test as an additional clinical measure of treatment response in panic disorder
by: Alexandre M. Valença, et al.
Published: (2002-06-01) -
Characteristics of patients with anxiety disorder without selective serotonin reuptake inhibitor prescription over a two‐year period of pharmacotherapy
by: Keisuke Mori, et al.
Published: (2024-03-01) -
The association between serotonin-related gene polymorphisms and susceptibility and early sertraline response in patients with panic disorder
by: Zhili Zou, et al.
Published: (2020-07-01) -
Double-blind clonazepam vs placebo in panic disorder treatment
by: ALEXANDRE MARTINS VALENÇA, et al.
Published: (2000-12-01) -
Basic features of panic disorder
by: Antonio W. Zuardi
Published: (2017-02-01)